Amgen Inc.Viés de alta
Amgen Inc. (AMGN)
Interesting graphical retracement for the Amgen stock which sees a considerable decline from the highs of the year. Where does the caution stem from? First, management highlighted that new patient prescriptions remain below pre-COVID-19 levels, and second, variants are suggesting demand may be muted for now. The stock has a solid capital appreciation potential and dividend growth prospects out to 2024-2026.
Annual Profit: 9.5 bil $
Total debt: 32.7 bil $
Annual Profit: 9.5 bil $
Total debt: 32.7 bil $
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.